Purchase of purified hyperimmune Equine Tetanus Antitoxin

The Agency requires the purchase of purified hyperimmune Equine Tetanus Antitoxin for use in the development of a replacement biological reference material. An overview of the requirement is: hyperimmune equine tetanus antitoxin obtained from the repeated immunisation of horses with tetanus toxoid and toxin. The suitable material would have a potency of at least 1,500 IU/ml in a total volume of not less than 5 L and will be purified F(ab)2. Material to be supplied in 2019. As far as we are aware there is only one s...